Literature DB >> 27585571

A preliminary in vivo study of the effects of OPN on rat liver regeneration induced by partial hepatectomy.

Gaiping Wang1,2, Congcong Zhao1,2, Shasha Chen1,2, Xiaofang Li1,2, Ling Zhang3, Cuifang Chang2, Cunshuan Xu4,5.   

Abstract

Osteopontin (OPN) is a member of Th1 cytokine secreted by activated lymphocytes and macrophages. However, it deserves to be studied whether OPN could promote cell activation or proliferation, and then facilitate hepatic self-repair during liver regeneration (LR). This study is designed to further reveal the effects of OPN on LR in vivo. Firstly, quantitative reverse transcription-PCR (qRT-PCR) and western blot (WB) were utilized to validate the expression profile of endogenous OPN in rat regenerating livers after partial hepatectomy (PH). Then OPN expression vector, two shRNA expression vectors and their respective test vectors were successfully constructed. Afterwards, test vectors were administrated into mouse livers via tail vein to find the more efficient shRNA. Furthermore, OPN expression vector and the more efficient shRNA expression vector were injected into rat regenerating livers, and then the changes in liver regeneration and hepatic microstructure were respectively detected by liver regeneration rate and HE staining, while the expressions of several marker genes were detected by qRT-PCR and WB. Endogenous OPN was strikingly up-regulated in both mRNA and protein level during LR, especially at 12 and 72 h after PH. The shRNA expression vector Opn(313) was found to be more efficient than Opn(887) in silencing the expression of Opn. Then OPN expression vector and Opn(313) were injected into rat remnant livers, and it showed that OPN overexpression aggravated hepatic necrosis and leukocytes infiltration, while OPN silencing inhibited liver regeneration rate and the expressions of PCNA and CCL2, but augmented that of BAX. In conclusion, OPN might enhance inflammation and cell proliferation, attenuate cell apoptosis, and ultimately facilitate liver regeneration at the termination stage of liver regeneration.

Entities:  

Keywords:  Osteopontin; Partial hepatectomy; Rat liver regeneration; Tail intravenous injection; shRNA

Mesh:

Substances:

Year:  2016        PMID: 27585571     DOI: 10.1007/s11033-016-4071-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  32 in total

Review 1.  Liver inflammation and regeneration: two distinct biological phenomena or parallel pathophysiologic processes?

Authors:  Maciej M Markiewski; Robert A DeAngelis; John D Lambris
Journal:  Mol Immunol       Date:  2006-01       Impact factor: 4.407

Review 2.  Liver regeneration: mechanisms, mysteries and more.

Authors:  Aamir Z Khan; Satvinder S Mudan
Journal:  ANZ J Surg       Date:  2007 Jan-Feb       Impact factor: 1.872

3.  Osteopontin expression in proliferated bile ductules: the correlation with liver damage in fulminant hepatitis.

Authors:  Takuma Tajiri; Genshu Tate; Toshiaki Kunimura; Yutaka Endo; Kazuaki Inoue; Toshiyuki Mitsuya; Toshio Morohoshi; Makoto Yoshiba
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

4.  Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.

Authors:  Renee J Phillips; Karla J Helbig; Kylie H Van der Hoek; Devanshi Seth; Michael R Beard
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

5.  The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.

Authors:  Peter Fickert; Andrea Thueringer; Tarek Moustafa; Dagmar Silbert; Judith Gumhold; Oleksiy Tsybrovskyy; Margitta Lebofsky; Hartmut Jaeschke; Helmut Denk; Michael Trauner
Journal:  Lab Invest       Date:  2010-04-05       Impact factor: 5.662

6.  Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.

Authors:  Rong-Xin Chen; Yun-Hong Xia; Tong-Chun Xue; Hong Zhang; Sheng-Long Ye
Journal:  Oncol Rep       Date:  2010-12-21       Impact factor: 3.906

7.  Gene expression profiles in liver regeneration with oval cell induction.

Authors:  Makoto Arai; Osamu Yokosuka; Kenichi Fukai; Fumio Imazeki; Tetsuhiro Chiba; Hajime Sumi; Masaki Kato; Masaki Takiguchi; Hiromitsu Saisho; Masaaki Muramatsu; Naohiko Seki
Journal:  Biochem Biophys Res Commun       Date:  2004-04-30       Impact factor: 3.575

Review 8.  Mechanisms of immune-mediated liver injury.

Authors:  David H Adams; Cynthia Ju; Shashi K Ramaiah; Jack Uetrecht; Hartmut Jaeschke
Journal:  Toxicol Sci       Date:  2010-01-13       Impact factor: 4.849

9.  Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.

Authors:  Jian Zhao; Li Dong; Bin Lu; Guobin Wu; Dongmei Xu; Jingjing Chen; Kai Li; Xin Tong; Jianxin Dai; Side Yao; Mengchao Wu; Yajun Guo
Journal:  Gastroenterology       Date:  2008-05-07       Impact factor: 22.682

10.  Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression.

Authors:  Yanhua Wu; Wenjun Jiang; Yingming Wang; Jun Wu; Hexige Saiyin; Xiaojing Qiao; Xinyu Mei; Bin Guo; Xiao Fang; Lu Zhang; Huiling Lou; Chaoqun Wu; Shouyi Qiao
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

View more
  6 in total

1.  Serum osteopontin is a predictor of prognosis for HBV-associated acute-on-chronic liver failure.

Authors:  Longgen Liu; Jianchun Lu; Chunyan Ye; Lin Lin; Shuqin Zheng; Hongyu Zhang; Qing Lan; Yuan Xue
Journal:  Biomed Rep       Date:  2017-12-13

Review 2.  Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Expert Rev Mol Diagn       Date:  2018-08-13       Impact factor: 5.225

Review 3.  Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?

Authors:  Tomoya Iida; Kohei Wagatsuma; Daisuke Hirayama; Hiroshi Nakase
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

Review 4.  Biomarkers of drug-induced liver injury: a mechanistic perspective through acetaminophen hepatotoxicity.

Authors:  David S Umbaugh; Hartmut Jaeschke
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2020-12-09       Impact factor: 3.869

5.  Administration of Ginkgo biloba Extract (EGb761) Alone and in Combination with FK506 Promotes Liver Regeneration in a Rat Model of Partial Hepatectomy.

Authors:  Nahide Ekici Günay; Sabahattin Muhtaroğlu; Abdulkadir Bedirli
Journal:  Balkan Med J       Date:  2018-03-15       Impact factor: 2.021

6.  Atorvastatin provides a new lipidome improving early regeneration after partial hepatectomy in osteopontin deficient mice.

Authors:  Maitane Nuñez-Garcia; Beatriz Gomez-Santos; Diego Saenz de Urturi; Daniela Mestre; Francisco Gonzalez-Romero; Xabier Buque; Virginia Gutiérrez-de Juan; María Luz Martinez-Chantar; Wing-Kin Syn; Olatz Fresnedo; Patricia Aspichueta
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.